Table 2.
HIV+ (NC) (N= 21) | MCI (N= 31) | HAD (N=34) | P value (ANOVA) | Post-hoc NC versus MCI | Post-hoc NC versus HAD | Post-hoc MCI versus HAD | |
---|---|---|---|---|---|---|---|
mI (*) | 3.4 ± 0.67 | 3.86 ± 0.85 | 4.15±0.75 | 0.006 | ns | <0.05 | ns |
Cho | 1.9 ± 0.39 | 1.78 ± 0.32 | 1.83 ± 0.32 | ns | ns | ns | ns |
Cr | 6.04 ± 0.79 | 5.96 ± 0.8 | 5.79 ± 0.62 | ns | ns | ns | ns |
Glu | 6.68 ± 1.2 | 6.3 ± 1.0 | 6.3 ± 1.1 | ns | ns | ns | ns |
Gln | 4.22 ± 0.4 | 4.6 ± 1.0 | 3.82±0.21 | ns | sn | ns | ns |
Glx (*) | 10.0 ± 1.62 | 9.17 ± 2.1 | 8.18 ± 2.1 | 0.006 | ns | <0.05 | ns |
NAA(*) | 7.67 ± 0.93 | 7.6 ± 1.04 | 7.1 ± 0.93 | 0.06 | ns | ns | ns |
mI/Cr (*) | 0.56 ± 0.19 | 0.67 ± 0.19 | 0.73 ± 0.15 | 0.004 | ns | <0.05 | ns |
Cho/Cr | 0.32 ± 0.05 | 0.29 ± 0.04 | 0.32 ± 0.06 | ns | ns | ns | ns |
Glu/Cr | 1.12 ± 0.2 | 1.06 ± 0.15 | 1.1 ± 0.2 | ns | ns | ns | ns |
Glx/Cr (*) | 1.67 ± 0.24 | 1.53 ± 0.26 | 1.42 ± 0.34 | 0.01 | ns | <0.05 | ns |
NAA/Cr | 1.28 ± 0.15 | 1.28 ± 0.09 | 1.23 ± 0.11 | ns | ns | ns | ns |
FWM = frontal white matter, Cho = choline, Cr = creatine, Glx = combined glutamate (Glu) and glutamine (Gln), NAA = sum of N-acetyl aspartate and N-acetyl aspartyl glutamate, mI = myo-Inositol. Normal cognition (NC), mild cognitive impairment (MCI) and HIV-associated dementia (HAD).
and values in bold = significant.